David Elliott
Medical Director
VA Ann Arbor Health Care Center
Clinical Associate Professor of Radiation Oncology
[email protected]

Available to mentor
David Elliott
Clinical Associate Professor
  • Recent Publications
    • Recent Publications See All Publications
    • Journal Article
      De-escalating adjuvant durvalumab treatment duration in stage III non-small cell lung cancer.
      Bryant AK, Sankar K, Zhao L, Strohbehn GW, Elliott D, Moghanaki D, Kelley MJ, Ramnath N, Green MD. Eur J Cancer, 2022 Aug; 171: 55 - 63. DOI:10.1016/j.ejca.2022.04.033
      PMID: 35704975
    • Patent
      Rectal Retractor with US probe for Creating Distance Between Prostate and Anterior Rectal Wall for Easy Insertion of Hydrogel to Avoid Dose to Rectum During Radiation Oncology Treatments
    • Journal Article
      Prognostic and Predictive Role of PD-L1 Expression in Stage III Non-small Cell Lung Cancer Treated With Definitive Chemoradiation and Adjuvant Durvalumab.
      Bryant AK, Sankar K, Strohbehn GW, Zhao L, Daniel V, Elliott D, Ramnath N, Green MD. Int J Radiat Oncol Biol Phys, 2022 Jul 15; 113 (4): 752 - 758. DOI:10.1016/j.ijrobp.2022.03.015
      PMID: 35450753
    • Journal Article
      Real World Outcomes versus Clinical Trial Results of Durvalumab Maintenance in Veterans with Stage III Non-Small Cell Lung Cancer.
      Sankar K, Bryant AK, Strohbehn GW, Zhao L, Elliott D, Moghanaki D, Kelley MJ, Ramnath N, Green MD. Cancers, 2022 Jan 26; 14 (3):
    • Journal Article
      Real World Outcomes versus Clinical Trial Results of Durvalumab Maintenance in Veterans with Stage III Non-Small Cell Lung Cancer.
      Sankar K, Bryant AK, Strohbehn GW, Zhao L, Elliott D, Moghanaki D, Kelley MJ, Ramnath N, Green MD. Cancers (Basel), 2022 Jan 26; 14 (3): DOI:10.3390/cancers14030614
      PMID: 35158881
    • Journal Article
      Real World Outcomes versus Clinical Trial Results ofDurvalumab Maintenance in Veterans with Stage III Non-SmallCell Lung Cancer
      Sankar K, Bryant AK, Strohbehn GW, Zhao L, Elliott D, Moghanaki D, Kelley MJ, Ramnath N, Green MD. Cancers, 2022 Jan 26; 14 (2): 614 - 623.
    • Journal Article
      Prognostic and Predictive Role of PD-L1 Expression in Stage III Non-small Cell Lung Cancer Treated With Definitive Chemoradiation and Adjuvant Durvalumab.
      Bryant AK, Sankar K, Strohbehn GW, Zhao L, Daniel V, Elliott D, Ramnath N, Green MD. International journal of radiation oncology, biology, physics, 2022 Jan 18; 2022 Apr 18;S0360-3016(22):
    • Journal Article
      De-escalating adjuvant durvalumab treatment duration in stage III non-small cell lung cancer.
      Bryant AK, Sankar K, Zhao L, Strohbehn GW, Elliott D, Moghanaki D, Kelley MJ, Ramnath N, Green MD. European journal of cancer (Oxford, England : 1990), 2022 Jan 12; 171: 55 - 63.